Sense Biodetection Ltd.

medical devices

About

Sense Biodetection Ltd. is a global molecular diagnostics company founded in 2013 and based in Abingdon Science Park, England, with a presence in Milford, Massachusetts. The company specializes in delivering lab-quality diagnostic results through its innovative Veros™ product platform, which enables rapid, instrument-free molecular testing. This platform combines advanced molecular amplification chemistries with disposable hardware, allowing for accurate diagnostics that can be performed in various settings. The company has launched its first product, Veros COVID-19, in select European and South American markets and is expanding its portfolio to address other diseases. Sense Biodetection focuses on providing accessible and affordable testing solutions for healthcare providers, patients, and healthcare systems, particularly in decentralized environments like home testing and clinics. The company is backed by prominent investors and has been integrated into Sherlock Biosciences and OraSure Technologies, enhancing its capabilities and market reach.

Technologies

Mimecast Microsoft Office 365 Amazon AWS Microsoft Azure Google Analytics Google Tag Manager Vimeo Linkedin Marketing Solutions Twitter Advertising WordPress.org Nginx Gauges Gravity Forms Mobile Friendly Google Font API Typekit Remote AI

Keywords

medical equipment manufacturing biosciences medical devices innovation biotech diagnostics research and development in the physical engineering and life sciences information technology healthcare technology medical technology customer service b2b regulatory compliance diagnostic solutions biotech pipeline medical research medical diagnostics research and development biotechnology acquisition health innovation medical testing healthcare biotech research strategic move user experience innovation pipeline healthtech

Location

30 The Quadrant, Abingdon, England, United Kingdom, OX14 3YS

Related Companies

Companies in the same industry